• Most Popular
  • Most Shared

Roche hepatitis C drug shows promise in mid-stage trial

Fri Nov 2, 2007 8:51am EDT

Stocks

   

Nov 2 (Reuters) - Roche (ROG.VX) said its experimental drug to treat chronic hepatitis C virus infection showed promising antiviral activity in a mid-stage trial when given in combination with two other drugs.

In the study, the experimental drug R1626 was administered to patients in combination with drugs Pegasys and Copegus. The virus could no longer be detected in up to 81 percent of patients after four weeks of treatment. (Reporting by Jennifer Robin Raj in Bangalore)



More from Reuters

This heart-wrenching picture of a mother and child at an an emergency feeding centre in in Tahoua, Niger, won international acclaim for incorporating beauty, horror and despair. Taken on August 1, 2005 by Finbarr O'Reilly.

Pictures of the Decade

    Pictures
    A customer is served at a counter inside a foreign exchange store displaying a poster of various banknotes including the Chinese yuan or renminbi (RMB) in Hong Kong November 20, 2009. REUTERS/Bobby Yip
    OUTLOOK 2010:

    Be careful what you wish for

    Pressure on China to loosen its grip on the yuan will continue but the U.S. should tread carefully. Here are five world market issues to watch.  Full Article 

    Global Markets
    Aurora, a 20-year-old Beluga whale, swims with her newborn calf after giving birth at the Vancouver Aquarium in Vancouver, British Columbia June 7, 2009. REUTERS/Andy Clark

    365 days for the doomed

    From polar bears to emperor penguins, endangered species will get top online billing in 2010 during the Year of Biodiversity.  Full Article 

    Green Business